Skip to main navigation Skip to search Skip to main content

Correction: Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype (Oncotarget (2015) 6 (1231–1248) DOI: 10.18632/oncotarget.2840)

  • Xiaoqun Dong
  • , Qiushi Lin
  • , Arihiro Aihara
  • , Yu Li
  • , Chiung Kuei Huang
  • , Waihong Chung
  • , Qi Tang
  • , Xuesong Chen
  • , Rolf Carlson
  • , Christina Nadolny
  • , Gregory Gabriel
  • , Mark Olsen
  • , Jack R. Wands
  • University of Rhode Island
  • University of Oklahoma
  • Brown University
  • Kennesaw State University
  • Midwestern University Glendale

Research output: Contribution to journalComment/debate

Abstract

This article has been corrected: Due to errors during processing, Figure 5D contains an incorrect image of H675Q MIA PaCa2. In addition, in Figure 7B, the images of ASPH MIA PaCa2 treated with or without MO-I-1100 were also incorrect. In panel 7D, the image of Vector MIA PaCa2 (upper left) was incorrect as well. The corrected figures 5 and 7 are shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original languageEnglish
Pages (from-to)6644-6646
Number of pages3
JournalOncotarget
Volume10
Issue number61
StatePublished - 2019

Fingerprint

Dive into the research topics of 'Correction: Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype (Oncotarget (2015) 6 (1231–1248) DOI: 10.18632/oncotarget.2840)'. Together they form a unique fingerprint.

Cite this